Brief treatment of BL2 (Burkitt’s lymphoma), Jeko-1, Z138 (both mantle cell lymphoma) and Toledo (germinal center lymphoma) resulted in robust activation of Ras (Fig. 3). Here, CADM1 is linked to mantle cell lymphoma.